ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
77 hedge funds and large institutions have $109M invested in Adamas Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-21
Holders Change %
-21.43%
% of All Funds
1.68%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
8
Increased
33
Reduced
19
Closed
27
Calls
$542K
Puts
$441K
Net Calls
+$101K
Net Calls Change
+$250K
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$4.8M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$8.83M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.58M |
| 4 |
KA
Kerrisdale Advisers
Miami,
Florida
|
$1.42M |
| 5 |
BlackRock
New York
|
$13.6M |
